Filter Results :

Your search for Pharmaceutical returned 23912 reports

Sort by


Zambia Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Zambian government will continue to boost social expenditure as President Lungu attempts to gain public favour in light of the August general elections. Fiscal revenues will increase gradually, in line with the copper sector's slow recovery, but real GDP growth in Zambia will sti...

$ 1,295.00

Read More

China Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil...

$ 1,295.00

Read More

Vietnam Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Leveraging Vietnam's National Expanded Immunisation Programme (EPI) will be of strategic benefit to multinational pharmaceutical firms with a strong vaccines portfolio. Government support for the initiative is expected to remain strong, which bodes well for firms as the EPI alleviate...

$ 1,295.00

Read More

Botswana Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Multinational drugmaker presence in Botswana will be limited to imports as the small market size and lack of investment incentives deter any large-scale investment plans. Although generic drugs will retain their dominance in terms of market share, as the burden of non-communicable...

$ 1,295.00

Read More

Chemical and Pharmaceutical Plants Construction in Algeria to 2019: Market Databook

22 Jul 2016  |  Published by:  Timetric
Synopsis 'Chemical and Pharmaceutical Plants Construction in Algeria to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, rep...

$ 500.00

Read More

Chemical and Pharmaceutical Plants Construction in Bulgaria to 2019: Market Databook

19 Jul 2016  |  Published by:  Timetric
Synopsis 'Chemical and Pharmaceutical Plants Construction in Bulgaria to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, re...

$ 500.00

Read More

Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and w...

$ 125.00

Read More

Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and...

$ 125.00

Read More

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and...

$ 125.00

Read More

CASI Pharmaceuticals Inc. (CASI) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
CASI Pharmaceuticals Inc. (CASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and wea...

$ 125.00

Read More

Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths a...

$ 125.00

Read More

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and w...

$ 125.00

Read More

Chemical and Pharmaceutical Plants Construction in Kuwait to 2019: Market Databook

14 Jul 2016  |  Published by:  Timetric
Synopsis'Chemical and Pharmaceutical Plants Construction in Kuwait to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repai...

$ 500.00

Read More

Mozambique Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Mozambique has a high-risk low-reward pharmaceutical market, which suffers from poor regulation, low per-capita spending and a high abundance of counterfeit medicines in circulation. Further, ongoing political violence and lack of transparency will continue discourage multinationa...

$ 1,295.00

Read More

Asia Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Asia is a key growth opportunity for pharmaceutical firms. The sector's growth is supported by a solid economic foundation, projected to outperform with an average real GDP growth of 5% as compared to 3% globally over the next five years. Economically, South East Asia is set to be...

$ 1,295.00

Read More
Total 23912 records.